Aoyi Technology, a domestic non‑invasive BCI firm, has signed a strategic
cooperation agreement with Weichuang Brain Science (02172.HK) to jointly develop
an interventional brain‑computer interface (BCI) rehabilitation system. The
design uses a minimally invasive endovascular route to deliver a
signal‑collection stent to targeted brain regions without craniotomy. Decoded
neural signals will be converted into motor control commands to drive a
lightweight exoskeleton robot, aimed at assisting stroke and spinal‑cord injury
patients and enabling closed‑loop neurofunctional rehabilitation. The partners
plan to begin clinical trials within one year.
